• Featured Product
  • KD/KO Validated

TPD52L2 Polyklonaler Antikörper

TPD52L2 Polyklonal Antikörper für IF, IHC, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IP, IHC, IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 11795-1-AP

Synonyme

D54, hD54, TPD52L2, TPD54, tumor protein D52 like 2, Tumor protein D54



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHEK-293-Zellen, Maushirngewebe, MCF-7-Zellen, Rattenhirngewebe
Erfolgreiche IPHEK-293-Zellen
Erfolgreiche Detektion in IHChumanes Mammakarzinomgewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
Erfolgreiche Detektion in IFHepG2-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:1000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)IHC : 1:50-1:500
Immunfluoreszenz (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

11795-1-AP bindet in WB, IP, IHC, IF, ELISA TPD52L2 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen TPD52L2 fusion protein Ag2364
Vollständiger Name tumor protein D52-like 2
Berechnetes Molekulargewicht 206 aa, 22 kDa
Beobachtetes Molekulargewicht 25-30 kDa
GenBank-ZugangsnummerBC006804
Gene symbol TPD52L2
Gene ID (NCBI) 7165
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Tumor protein D52-like proteins (TPD52) are small coiled-coil motif bearing proteins that were first identified in breast carcinoma. Three human TPD52 members had been identified, named hD52 (TPD52), hD53 (TPD52L1), and hD54 (TPD52L2). The most important characteristic of the protein family is a highly conserved coiled-coil motif that is required for homo- and heteromeric interaction with other TPD52-like proteins. TPD52 and related proteins have been implicated in cell proliferation, apoptosis, and vesicle trafficking. TPD52L2 has five isoforms produced by alternative splicing, and its multiple sites have been identified to be phosphorylated. Interaction of TPD52L2 with MAL2, a novel member of the MAL proteolipid family, may be required for the role of TPD52L2 in vesicle transport.

Protokolle

Produktspezifische Protokolle
WB protocol for TPD52L2 antibody 11795-1-APProtokoll herunterladen
IHC protocol for TPD52L2 antibody 11795-1-APProtokoll herunterladen
IF protocol for TPD52L2 antibody 11795-1-APProtokoll herunterladen
IP protocol for TPD52L2 antibody 11795-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Carcinogenesis

TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling.

Authors - Zhou Qiang
  • KD Validated
humanWB

Cell Biosci

Tumor protein D52 is upregulated in oral squamous carcinoma cells under hypoxia in a hypoxia-inducible-factor-independent manner and is involved in cell death resistance.

Authors - Yuzo Abe
humanIF

J Biol Chem

Tumor protein D54 binds intracellular nanovesicles via an extended amphipathic region.

Authors - Antoine Reynaud
human,mouseWB,IHC,IP

Int J Oncol

Opposite effects of tumor protein D (TPD) 52 and TPD54 on oral squamous cell carcinoma cells.

Authors - Kosuke Kato
mouseWB,IHC

Biomed Res Int

Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of Chondrocytes.

Authors - Chihiro Ito
humanWB

Neoplasma

Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway.

Authors - Z Wang
  • KD Validated

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Jerome (Verified Customer) (01-05-2020)

Puncta in the cytoplasm

  • Applications: Immunofluorescence,
  • Primary Antibody Dilution: 1:100
  • Cell Tissue Type: HeLa cells
TPD52L2 Antibody Immunofluorescence, validation (1:100 dilution) in HeLa cells (Cat no:11795-1-AP)